LONP1 and glioma: In our study, using a specific Lon inhibitor CC4, we demonstrated that CC4 not only significantly suppressed glioma cell growth, but further potentiated the antitumor effects of two commonly used chemotherapy drugs with cross the blood-brain barrier and have proven activity in brain malignancies, TMZ and cisplatin (Figure 5).